Facetten
Zugriff
Einrichtung
Medientyp
- Text 3
Karte
Erscheinungsjahr
Autor/in
- Weisel, Katja
- Zahlten-Kumeli, Anita
- Leleu, Xavier 2
- Siegel, David 2
- Cavo, Michele 1
- alle zeigen
Sprache
- Englisch 3
3 Einträge gefunden
-
Health-related quality of life outcomes from the CANDOR study in patients with relapsed or refractory multiple myeloma
2021 - Forschungsinformationssystem des UKE - frei zugänglich -
Once- versus twice-weekly carfilzomib in relapsed and refractory multiple myeloma by select patient characteristics: phase 3 A.R.R.O.W. study subgroup analysis
- Dimopoulos, Meletios A
- Niesvizky, Ruben
- Weisel, Katja
- Siegel, David S
- Hajek, Roman
- Mateos, María-Victoria
- Cavo, Michele
-
Carfilzomib, dexamethasone, and daratumumab versus carfilzomib and dexamethasone for patients with relapsed or refractory multiple myeloma (CANDOR): results from a randomised, multicentre, open-label, phase 3 study
- Dimopoulos, Meletios
- Quach, Hang
- Mateos, Maria-Victoria
- Landgren, Ola
- Leleu, Xavier
- Siegel, David
- Weisel, Katja